LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, a leading provider of injectable medications, announced today it has launched Rocuronium Bromide Injection with advanced RFID-enabled labels in the ...
B. Braun Medical Inc. (B. Braun), a recognized leader in smart infusion therapy and pharmaceutical manufacturing, announced the launch of Rocuronium Bromide Injection, the first and only FDA-approved, ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--#CommittedToLife--Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has ...
SCHAUMBURG, Ill., Aug. 2 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced two FDA approvals -- sumatriptan succinate injection and ...
Fresenius Kabi, a provider of injectable medications, has announced the U.S. launch of its Rocuronium Bromide Injection, a product offered with RFID-enabled labels. Rocuronium Bromide Injection is ...
Fresenius Kabi, an operating company of Fresenius, and a leading provider of essential medicines and medical technologies, announced it has launched rocuronium bromide injection room temperature ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results